TickerFactsScreenerDevelopers

Tonix Pharmaceuticals Holding Corp. (TNXP) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2007: -$415.0K2008: -$545.0K2009: -$537.0K2010: -$175.0K2011: -$2.45M2012: $959.0K2013: $6.51M2014: $36.09M2015: $40.26M2016: $25.36M2017: $24.62M2018: $23.66M2019: $9.42M2020: $87.65M2021: $218.72M2022: $207.18M2023: $105.53M2024: $139.56M2025: $245.15M$245.15M
2007Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$245.15M+75.7%
2024$139.56M+32.3%
2023$105.53M-49.1%
2022$207.18M-5.3%
2021$218.72M+149.5%
2020$87.65M+830.7%
2019$9.42M-60.2%
2018$23.66M-3.9%
2017$24.62M-2.9%
2016$25.36M-37.0%
2015$40.26M+11.6%
2014$36.09M+454.2%
2013$6.51M+579.0%
2012$959.0K+139.1%
2011-$2.45M-1302.3%
2010-$175.0K+67.4%
2009-$537.0K+1.5%
2008-$545.0K-31.3%
2007-$415.0K—